Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy - Concepedia

Concepedia

Publication | Open Access

Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy

DOI Full Paper Access

32

Citations

24

References

2013

Year

Josef Veselka, Thorsten Lawrenz, Christoph Stellbrink, David Zemánek, Marian Branny, Jaroslav Januška, Jan Sitar, Jan Krejčí, Maciej Dąbrowski, S Mizera,

Catheterization and Cardiovascular Interventions

Abstract

The results of the first European multicenter and multinational study demonstrate that real-world early outcomes of ASA patients are better than was reported in observations from the first decade after ASA introduction.

References

	Year	Citations
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Circulation CardiomyopathyCardiovascular DiseaseHypertrophic CardiomyopathyCardiac CareMedicine	2011	2.1K
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Ulrich Sigwart The Lancet Cardiac MuscleCardiomyopathyNon-surgical Myocardial ReductionCardiovascular DiseaseMedicine	1995	790
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy Martin S. Maron, Iacopo Olivotto, Caitlin Harrigan, Circulation	2011	446
Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy Paul Sorajja, Uma Valeti, Rick A. Nishimura, Circulation	2008	313
Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy Paul Sorajja, Steve R. Ommen, David R. Holmes, Circulation	2012	287
Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy Sherif F. Nagueh, Bertron Μ. Groves, Leonard Schwartz, Journal of the American College of Cardiology Alcohol Septal AblationHeart FailureCardiothoracic SurgeryCardiomyopathyCardiac Anaesthesia	2011	204
Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience Laura M. Faber European Journal of Echocardiography	2004	152
Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience H. Kuhn, Thorsten Lawrenz, Frank Lieder, Clinical Research in Cardiology Transcoronary AblationCardiac MuscleCardiomyopathyHeart FailureCardiogenic Shock	2007	132
Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy Valerian Fernandes, Christopher D. Nielsen, Sherif F. Nagueh, JACC: Cardiovascular Interventions Alcohol Septal AblationHeart FailureCardiomyopathyStructural Heart DiseaseMedicine	2008	108
Long-Term Outcome of Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy Morten K. Jensen, Vibeke Marie Almaas, Linda Jacobsson, Circulation Cardiovascular Interventions	2011	107

Page 1